顯示具有 Tobacco Industry 標籤的文章。 顯示所有文章
顯示具有 Tobacco Industry 標籤的文章。 顯示所有文章

2026年5月6日 星期三

The Pious Parasite: Why the State Loves Your Sins

 

The Pious Parasite: Why the State Loves Your Sins

In the cold logic of the savanna, a primate that consumes fermented fruit isn't just seeking a buzz; it’s engaging in a high-risk, high-reward search for easy calories. Today, that primate is a Londoner sitting in a pub, and the "alpha" of the tribe—the State—is waiting to take its cut. When you pay £6 for a pint, you aren’t just paying for hops and malt. You are paying a "pious tax." Between alcohol duty and VAT, HMRC siphons off £1.69 before the publican even covers the cost of the glass.

From an evolutionary perspective, the State functions as a sophisticated parasite. It doesn’t want to kill the host (the drinker), but it wants to bleed it just enough to stay fed. By labeling alcohol and tobacco as "sins," the government gains a moral mandate to extract a staggering £24 billion a year. It is the ultimate business model: monetize the darker, addictive corners of human nature while claiming the high ground of "public health." If the State truly wanted to stop smoking and drinking, it would ban them. Instead, it prices them just high enough to maximize revenue without triggering a total withdrawal or a riot.

The cynicism is most visible in the "Draught Relief." By lowering the tax on a pint at the bar compared to a can at the supermarket, the State is attempting to nudge the primates back into the "supervised" communal drinking of the pub rather than the "unregulated" solitude of the home. It’s about control. Meanwhile, tobacco duty has become a regressive trap. We know the poorest 20% pay nearly three times more of their income into this pot than the wealthy, yet we defend it with a straight face because "smoking is bad."

Ultimately, we are trapped in a biological loop. We seek the dopamine of the vice, and the State seeks the revenue of the tax. We pretend to be a civilization of self-controlled rationalists, but our national budget is held together by the staggering volume of pints we sink and the cigarettes we burn. The Treasury isn't your doctor; it’s your dealer, and business is booming.



2026年3月17日 星期二

The Addict’s Dividend: Why Dying Industries are Killing It

 

The Addict’s Dividend: Why Dying Industries are Killing It

There is a dark irony in the fact that one of the greatest triumphs of public health—the near-extinction of the American smoker—has become the ultimate gold mine for Wall Street. While the number of smokers has cratered from 45% in the 1950s to a mere 11% today, the companies selling the poison are more profitable than ever. Since 2024, tobacco stocks have actually outpaced the "white-hot" Nasdaq. It turns out, you don't need a growing customer base if you have a customer base that literally cannot quit.

The Physics of Addiction: Price Inelasticity

Human nature, specifically the biology of addiction, has broken the traditional laws of economics.

  • The "Hardcore" Remnant: When 45% of people smoked, many were "social smokers" who would quit if the price of a pack jumped. Today’s 11% are the most committed, addicted, and price-insensitive cohort in history. To them, a cigarette isn't a luxury; it's a physiological necessity.

  • The Margin Miracle: Tobacco companies have realized they can hike prices far above inflation. In 2024, while the world worried about a 3% CPI, Marlboro prices leaped by 7%. This has pushed operating margins to a staggering 60%. Big Tobacco has successfully pivoted from a volume business to a "premium extraction" business.

The Regulatory Moat: Big Government as Big Tobacco's Bodyguard

In a truly free market, a 60% margin would invite a swarm of competitors. But the US cigarette market is a duopoly protected by a wall of red tape.

  • The Compliance Trap: Decades of "heavy regulation" intended to kill the industry have actually saved it. The cost of complying with vast government mandates is so high that no small startup could ever hope to enter the market.

  • The Protected Duopoly: Altria and British American Tobacco sit behind a moat dug by the very regulators who hate them. With no new rivals allowed in the "dark room," these two giants can coordinate price hikes with the clinical efficiency of a cartel.

History shows that "sin" industries often perform best when they are under siege. By shrinking the market to its most addicted core and using regulation to kill competition, Big Tobacco has achieved a state of "financial immortality" that would make Silicon Valley blush.